Skip to search.
 TSX Down 0.39% TSX Ventures Up 0.28%

Delcath Systems, Inc. (DCTH)

-NasdaqCM
1.01 Down 0.04(3.81%) Mar 27, 3:58PM EDT
Add to Portfolio
Prev Close:1.05
Open:1.06
Bid:0.79 x 700
Ask:1.07 x 500
1y Target Est:1.30
Beta:1.41
Next Earnings Date:N/A
Day's Range:1.00 - 1.11
52wk Range:0.97 - 4.96
Volume:134,285
Avg Vol (3m):130,103
Market Cap:9.81M
P/E (ttm):N/A
EPS (ttm):-1.84
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
DCTHDown 3.81%9.81M
LLYUp 0.19%78.04B
ONXX 0.00%N/A
PFEUp 1.08%211.63B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):9.54
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :N/A
Quarterly EPS Est (Jun-14) :N/A
Mean Recommendation*:4.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Delcath Systems, Inc. operates as a specialty pharmaceutical and medical device company focusing on cancers of the liver. The company is developing its proprietary product-Melphalan Hydrochloride for injection for use with the Delcath Hepatic Deli... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback